BECHERINI, CARLOTTA
 Distribuzione geografica
Continente #
NA - Nord America 2.327
EU - Europa 1.577
AS - Asia 514
AF - Africa 9
Totale 4.427
Nazione #
US - Stati Uniti d'America 2.321
RU - Federazione Russa 845
IT - Italia 309
IE - Irlanda 177
HK - Hong Kong 144
CN - Cina 133
SG - Singapore 131
SE - Svezia 119
JO - Giordania 46
IN - India 40
DE - Germania 30
PL - Polonia 24
GB - Regno Unito 21
FI - Finlandia 18
KR - Corea 10
CH - Svizzera 7
FR - Francia 7
UA - Ucraina 7
CI - Costa d'Avorio 6
CA - Canada 5
CY - Cipro 3
NL - Olanda 3
BE - Belgio 2
CZ - Repubblica Ceca 2
DK - Danimarca 2
ID - Indonesia 2
JP - Giappone 2
LT - Lituania 2
TN - Tunisia 2
VN - Vietnam 2
ES - Italia 1
GL - Groenlandia 1
GR - Grecia 1
NG - Nigeria 1
PH - Filippine 1
Totale 4.427
Città #
Santa Clara 595
Fairfield 207
Chandler 185
Dublin 177
Ashburn 148
Seattle 123
Woodbridge 117
Hong Kong 102
Singapore 94
Cambridge 91
Wilmington 82
Houston 76
Altamura 46
Dearborn 45
Lawrence 43
Ann Arbor 37
Beijing 35
Princeton 31
Shanghai 31
Moscow 27
Mumbai 26
Florence 25
Kent 25
Buffalo 24
Warsaw 24
Boston 23
New York 22
San Diego 19
Los Angeles 16
Helsinki 12
Medford 10
Munich 10
Rome 10
Seoul 10
Pune 9
Yubileyny 9
Boardman 8
Milan 8
Naples 8
West Jordan 8
London 7
Abidjan 6
Guangzhou 6
Shenzhen 6
Hillsboro 5
Somma Vesuviana 5
Fiesole 4
Maddaloni 4
Padova 4
Qingdao 4
Wuhan 4
Zurich 4
Acerra 3
Alice Castello 3
Andover 3
Andria 3
Bern 3
Eboli 3
Falls Church 3
Fontebuona 3
Frankfurt am Main 3
Grezzana 3
Hefei 3
Nanjing 3
Nola 3
Norwalk 3
Paphos 3
Pontedera 3
Prato 3
Qualiano 3
Redmond 3
San Felice A Cancello 3
St Louis 3
Toronto 3
Zhengzhou 3
Avellino 2
Aversa 2
Bologna 2
Brno 2
Brussels 2
Bussolengo 2
Calgary 2
Campi Bisenzio 2
Castellammare di Stabia 2
Dallas 2
Dong Ket 2
Dongyang 2
Empoli 2
Falkenstein 2
Fisciano 2
Kilburn 2
Lucera 2
Messadine 2
Modena 2
Nagold 2
Nutley 2
Nürnberg 2
Pagani 2
Pelago 2
Perugia 2
Totale 2.776
Nome #
SAFE trial: an ongoing randomized clinical study to assess the role of cardiotoxicity prevention in breast cancer patients treated with anthracyclines with or without trastuzumab 154
Disease-specific and general health-related quality of life in newly diagnosed prostate cancer patients: The Pros-IT CNR study 153
A PPAR gamma agonist protects against oral mucositis induced by irradiation in a murine model 148
Use of an alpha lipoic, methylsulfonylmethane and bromelain dietary supplement (Opera®) for chemotherapy-induced peripheral neuropathy management, a prospective study 146
Influence of age and subtype in outcome of operable liposarcoma 146
External accelerated partial breast irradiation for ductal carcinoma in situ: long-term follow-up from a phase 3 randomized trial 134
Safety of concurrent adjuvant radiotherapy and chemotherapy for locally advanced soft tissue sarcoma 128
Patterns of Care and Survival in Elderly Patients With Locally Advanced Soft Tissue Sarcoma 126
Benefit of ablative versus palliative-only radiotherapy in combination with nivolumab in patients affected by metastatic kidney and lung cancer 126
Phase 2 placebo-controlled, single-blind trial to evaluate the impact of oral ibandronate on bone mineral density in osteopenic breast cancer patients receiving adjuvant aromatase inhibitors: 5-year results of the single-centre BONADIUV trial 125
Radiotherapy in the age of cancer immunology: Current concepts and future developments 121
Enhancement of Soft Tissue Sarcoma Cell Radiosensitivity by Poly(ADP-ribose) Polymerase-1 Inhibitors 112
European Society for Radiotherapy and Oncology Advisory Committee in Radiation Oncology Practice consensus recommendations on patient selection and dose and fractionation for external beam radiotherapy in early breast cancer 108
Partial breast irradiation for ductal carcinoma in situ: The Goldilocks principle? 105
Pros-IT CNR: an Italian prostate cancer monitoring project 105
Assessment of a guideline-based heart substructures delineation in left-sided breast cancer patients undergoing adjuvant radiotherapy: Quality assessment within a randomized phase III trial testing a cardioprotective treatment strategy (SAFE-2014) 100
Combination of novel systemic agents and radiotherapy for solid tumors – Part II: An AIRO (Italian association of radiotherapy and clinical oncology) overview focused on treatment toxicity 100
Outcome and prognostic factors for older patients undergoing radiosurgery for brain metastases 100
The Potential Role of Intensity-modulated Proton Therapy in the Regional Nodal Irradiation of Breast Cancer: A Treatment Planning Study 99
Combination of novel systemic agents and radiotherapy for solid tumors – part I: An AIRO (Italian association of radiotherapy and clinical oncology) overview focused on treatment efficacy 92
The Italian Association for Radiotherapy and Clinical Oncology (AIRO) position statements for postoperative breast cancer radiation therapy volume, dose, and fractionation 82
Use of an alfa-lipoic, Methylsulfonylmethane, Boswellia serrata and Bromelain dietary supplement (OPERA®) for aromatase inhibitors-related arthralgia management (AIA): a prospective phase II trial (NCT04161833) 75
Breast reconstruction and radiation therapy: An Italian expert Delphi consensus statements and critical review 73
Association of Breast Cancer Irradiation with Cardiac Toxic Effects: A Narrative Review 71
Clinical outcome of stereotactic body radiotherapy for lung-only oligometastatic head and neck squamous cell carcinoma: Is the deferral of systemic therapy a potential goal? 66
Stereotactic body radiation therapy (SBRT) on renal cell carcinoma, an overview of technical aspects, biological rationale and current literature 66
Cardioprotective Strategy for Patients with Nonmetastatic Breast Cancer Who Are Receiving an Anthracycline-Based Chemotherapy: A Randomized Clinical Trial 66
Pre-pectoral breast reconstruction: early and long-term safety evaluation of 146 unselected cases of the early pre-pectoral era of a single-institution, including cases with previous breast irradiation and post-mastectomy radiation therapy 66
Tumor-associated macrophages (TAMs) modulate response to HER2-targeted agents in a humanized mouse model of breast cancer 65
Is there a worthwhile value in personalizing radiation therapy for breast cancer patients? Time for a new paradigm in the older adult population 65
Integrating radiation therapy with targeted treatments for breast cancer: From bench to bedside 63
Predictive factors for tolerance to taxane based chemotherapy in older adults affected by metastatic prostate cancer (ANCHISES-NCT05471427): A prospective observational trial including patients with metastatic hormone sensitive and castrate resistant prostate cancer treated with taxane chemotherapy 62
Early biochemical outcomes following PSMA guided approach for bIoCHEmical relapse after prostatectomy-PSICHE trial (NCT05022914): preliminary results 59
Acupuncture for radiation-induced toxicity in head and neck squamous cell carcinoma: a systematic review based on PICO criteria 59
Safety of concurrent adjuvant radiotherapy and chemotherapy for locally advanced soft tissue sarcoma 58
Safety of CDK4/6 inhibitors and concomitant radiation therapy in patients affected by metastatic breast cancer 57
Preoperative robotic radiosurgery for early breast cancer: Results of the phase II ROCK trial (NCT03520894) 57
null 57
Durvalumab with cetuximab and radiotherapy for locally advanced squamous cell carcinoma of the head and neck: A phase 1/2 trial 56
PSMA guided approach for bIoCHEmical relapse after prostatectomy- (PSICHE) trial (NCT05022914). Detection rate and treatment decision after 68Ga-PSMA PET/CT within a prospective study 55
Palliative radiotherapy in older adults with head and neck squamous cell carcinoma: A systematic review 55
Modulation of tumor-associated macrophage activity with radiation therapy: a systematic review 53
Application of Radiomics for the Prediction of Radiation-Induced Toxicity in the IMRT Era: Current State-of-the-Art 51
Management of severe bio-radiation dermatitis induced by radiotherapy and cetuximab in patients with head and neck cancer: emphasizing the role of calcium alginate dressings 49
The impact of patient preference in the treatment algorithm for recurrent/metastatic head and neck squamous cell carcinoma 49
Radiosensitizing Effect of Trabectedin on Human Soft Tissue Sarcoma Cells 47
Radiomics in the setting of neoadjuvant radiotherapy: A new approach for tailored treatment 46
Three Months' PSA and Toxicity from a Prospective Trial Investigating STereotactic sAlvage Radiotherapy for Macroscopic Prostate Bed Recurrence after Prostatectomy-STARR (NCT05455736) 43
Robotic stereotactic radiotherapy for liver oligometastases from colorectal cancer: a single-center experience 43
Essential requirements for reporting radiation therapy in breast cancer clinical trials: An international multi-disciplinary consensus endorsed by the European Society for Radiotherapy and Oncology (ESTRO) 40
Safety profile of trastuzumab-emtansine (T-DM1) with concurrent radiation therapy: a systematic review and meta-analysis 38
Stereotactic reirradiation with CyberknifeR for locally recurrent prostate cancer, long-term toxicity and clinical outcomes from a monocentric cohort 38
Radiobiology of stereotactic radiotherapy 37
Safety profile of cyclin-dependent kinase (CDK) 4/6 inhibitors with concurrent radiation therapy: A systematic review and meta-analysis 35
International multidisciplinary consensus on the integration of radiotherapy with new systemic treatments for breast cancer: European Society for Radiotherapy and Oncology (ESTRO)-endorsed recommendations 34
Radiation therapy on the axilla after neoadjuvant chemotherapy 34
Subclinical cardiac damage monitoring in breast cancer patients treated with an anthracycline-based chemotherapy receiving left-sided breast radiation therapy: subgroup analysis from a phase 3 trial 21
Quality of life after definitive treatment for bladder cancer: A systematic review and meta-analysis 20
Management of the axilla in breast cancer patients: critical review, regional modified Delphi consensus and implementation in the Tuscan breast network 18
Pre-pectoral breast reconstruction with tissue expander entirely covered by acellular dermal matrix: feasibility, safety and histological features resulting from the first 64 procedures 16
Anatomical assessment of local recurrence site in breast cancer patients after breast reconstruction and post-mastectomy radiotherapy: implications for radiation volumes and techniques 13
Totale 4.486
Categoria #
all - tutte 17.085
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 17.085


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/2020537 0 0 0 0 107 96 93 71 78 50 35 7
2020/2021226 27 13 15 34 10 7 9 20 23 27 21 20
2021/2022183 6 8 6 12 5 11 2 23 12 7 27 64
2022/2023867 52 153 49 24 67 153 103 92 120 4 27 23
2023/2024606 28 46 61 36 45 83 43 141 22 28 52 21
2024/20251.830 100 306 155 523 746 0 0 0 0 0 0 0
Totale 4.486